文献速递临床试验与 GCP基础与转化研究

多奈哌齐预防老年骨科手术患者术后认知功能障碍的多中心随机对照试验方案

Efficiency of donepezil in elderly patients undergoing orthopaedic surgery due to underlying post-operative cognitive dysfunction: study protocol for a multicentre randomised controlled trial.
PubMed 文献 · Trials · 2021-10-09

本研究为多中心、双盲、安慰剂对照、交叉临床试验,计划纳入360例老年骨科手术患者,从术前1天至术后5天给予多奈哌齐5mg每日一次或安慰剂,以神经心理测试评估术后1周、1个月、6个月和1年的认知功能,旨在明确多奈哌齐对术后认知功能障碍的预防作用及其神经生物学机制。

要点

  • 多奈哌齐5mg每日一次用于老年骨科手术患者围术期。
  • 主要观察术后1周至1年多个时间点的神经心理测试变化。
  • 前期动物实验提示多奈哌齐可预防麻醉/手术后学习记忆损害。

核心结论

  • 该试验旨在确定多奈哌齐在预防老年骨科手术患者认知功能障碍中的关键作用。
  • 结果可能为开发针对术后认知功能障碍的药物干预策略提供重要启示。

研究设计与样本

  • 多中心、双盲、安慰剂对照、交叉临床试验。
  • 计划纳入360例接受骨科手术的老年患者。
  • 干预为多奈哌齐5mg每日一次或安慰剂,从术前1天至术后5天。
  • 神经心理测试在术前1天及术后1周、1个月、6个月和1年进行。

主要发现

  • 前期研究显示脑脊液中胆碱乙酰转移酶浓度是术后认知功能障碍的预测因素。
  • 老年小鼠中多奈哌齐可预防麻醉/手术后的学习与记忆损害。

关键数值与推荐

  • 多奈哌齐剂量为5mg每日一次。
  • 给药时间为术前1天至术后5天。
  • 认知评估时间点为术前1天及术后1周、1个月、6个月和1年。

临床怎么用

  • 若试验证实有效,多奈哌齐可能成为老年骨科手术患者预防术后认知功能障碍的围术期用药选择。

局限性

  • 本文为研究方案,尚未报告试验结果,无法评估多奈哌齐的实际疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-operative cognitive dysfunction (POCD) is an overarching term used to describe cognitive impairment identified in the preoperative or post-operative period. After surgical operations, older patients are particularly vulnerable to memory disturbances and other types of cognitive impairment. However, the pathogenesis of POCD remains unclear with no confirmed preventable or treatable strategy available. Our previous study demonstrated that the concentration of choline acetyl transferase in the cerebral spinal fluid was a predictive factor of POCD and that donepezil, which is an acetylcholinesterase inhibitor used in clinical settings for the treatment of Alzheimer's disease, can prevent learning and memory impairment after anaesthesia/surgery in aged mice. This study aimed to determine the critical role of donepezil in preventing cognitive impairment in elderly patients undergoing orthopaedic surgery. METHODS: A multicentre, double-blind, placebo-controlled, crossover clinical trial will be performed to assess the efficacy of donepezil in elderly patients undergoing orthopaedic surgery. Participants (n = 360) will receive donepezil (5 mg once daily) or placebo from 1 day prior to surgery until 5 days after surgery. Neuropsychological tests will be measured at 1 day before the operation and 1 week, 1 month, 6 months and 1 year after the operation. DISCUSSION: This research project mainly aimed to study the effects of donepezil in elderly patients undergoing orthopaedic surgery due to underlying POCD and to investigate the underlying physiological and neurobiological mechanisms of these effects. The results may provide important implications for the development of effective interfering strategies, specifically regarding cognitive dysfunction therapy using drugs. TRIAL REGISTRATION: ClinicalTrials.gov NCT04423276 . Registered on 14 June 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhu H, Cong L, Chen Y, et al. Efficiency of donepezil in elderly patients undergoing orthopaedic surgery due to underlying post-operative cognitive dysfunction: study protocol for a multicentre randomised controlled trial. Trials. 2021. PMID: 34627332. doi:10.1186/s13063-021-05648-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。